Literature DB >> 17010370

Rapid and efficient identification of epitopes/mimotopes from random peptide libraries.

Xiaoli Yu1, Gregory P Owens, Donald H Gilden.   

Abstract

Phage-displayed random peptide libraries are important tools in identifying novel epitopes/mimotopes that may lead to the determination of antigen specificity. In this approach, high-affinity phage peptides are enriched by affinity selection (panning) on a monoclonal antibody. To facilitate identification of all potential phage peptides specific for recombinant monoclonal antibodies (rAbs) previously generated from clonally expanded plasma cells from the cerebrospinal fluid of patients with multiple sclerosis (MS), we developed a high-throughput method to determine phage specificity. In contrast to the 8-9 days needed in the standard large-scale method of amplifying phage clones for ELISA, the high-throughput method takes only 1 day. ELISA using phage clones amplified directly in 96-well plates avoids large-scale phage purification and enables rapid identification of specific epitopes/mimotopes. This technique will expedite identification of MS-specific peptides that can be used to discover the corresponding protein antigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010370     DOI: 10.1016/j.jim.2006.08.006

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Authors:  Xiaoli Yu; Mark Burgoon; Miyoko Green; Olga Barmina; Kathryn Dennison; Tiffany Pointon; Molly Davis; Don Gilden
Journal:  J Neuroimmunol       Date:  2011-11-12       Impact factor: 3.478

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

3.  Identification of peptide targets in neuromyelitis optica.

Authors:  Xiaoli Yu; Miyoko Green; Don Gilden; Chiwah Lam; Katherine Bautista; Jeffrey L Bennett
Journal:  J Neuroimmunol       Date:  2011-05-28       Impact factor: 3.478

4.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

5.  Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.

Authors:  Osmany Larralde; Juraj Petrik
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

6.  Identification of amino acids essential for antibody binding by mRNA-display using a random peptide library: an anti-human tumor protein p53 antibody as a model.

Authors:  Miwa Shiratori; Teruaki Kobayashi; Tatsuro Shibui
Journal:  Mol Biotechnol       Date:  2008-10-15       Impact factor: 2.695

7.  Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries.

Authors:  Xiaoli Yu; Olga Barmina; Mark Burgoon; Don Gilden
Journal:  J Virol Methods       Date:  2009-01-03       Impact factor: 2.014

8.  Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR.

Authors:  Xiaoli Yu; Mark P Burgoon; Andrew J Shearer; Donald H Gilden
Journal:  J Immunol Methods       Date:  2007-07-18       Impact factor: 2.303

9.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

Review 10.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.